Discuss This Drug

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

CHEBI:CHEBI_746891

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

brand_name_base
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA AUTHORIZED GENERIC
dosage_form
CAPSULE, EXTENDED RELEASE
labeler_name
Oryza Pharmaceuticals Inc.
generic_name
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
brand_name
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
product_ndc
72162-2053
application_number
ANDA040444
listing_expiration_date
20241231
route
ORAL
marketing_start_date
20011011
spl_id
fca80382-cd8a-4ae6-b150-45af596bd8d5
package_ndc
72162-2053-9
dea_schedule
CII
pharm_class
Central Nervous System Stimulation [PE]
brand_name_suffix
XR
upc
0311534191035
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
package_description
90 TABLET in 1 BOTTLE (72162-2053-9)
rxcui
861238
manufacturer_name
Oryza Pharmaceuticals Inc.
package_marketing_start_date
20020522
active_ingredient_strength
1.25 mg/1
active_ingredient_name
AMPHETAMINE ASPARTATE
unii
H527KAP6L5
spl_set_id
aa87c385-8e6f-49d5-951c-0c9f4ee1042e